𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)

✍ Scribed by Poddubnyy, D.; Hermann, K.-G. A.; Callhoff, J.; Listing, J.; Sieper, J.

Book ID
125496435
Publisher
BMJ Publishing Group
Year
2014
Tongue
English
Weight
929 KB
Volume
73
Category
Article
ISSN
0003-4967

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Improvements In Productivity At Paid Wor
Improvements In Productivity At Paid Work And Within Household, And Increased Participation In Daily Activities After 24 Weeks Of Certolizumab Pegol Treatment Of Axial Spondyloarthritis Patients, Including Patients With Ankylosing Spondylitis: Results Of A Phase 3 Double-Blind Randomized Placebo-Controlled Study
✍ van der Heijde, D.; Braun, J.; Rudwaleit, M.; Purcaru, O.; Kavanaugh, A. πŸ“‚ Article πŸ“… 2013 πŸ› John Wiley and Sons 🌐 English βš– 90 KB